Genetic Susceptibility to Tuberculosis and the Utility of Polygenic Scores in Population Stratification
International Journal of Molecular Sciences · 30.09.2025 · 26 (19) · 9544
DOI: 10.3390/ijms26199544 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.09.2025. Verfasst von Mariia A Dashian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical and Biological A…. Hauptthemen laut MEDLINE: Tuberculosis, Genetic Predisposition to Disease, Multifactorial Inheritance. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Tuberculosis (TB) is one of the leading infectious causes of mortality worldwide. Although a significant proportion of the population (up to 36%, depending on the region) is infected with the latent form of TB, only about one in ten of these people will develop an active form of the disease in their lifetime. This is due to a complex interaction between the host’s genetic predisposition and environment. However, the genetic determinants of TB are not well established and have been insufficiently explored in previous genome-wide association studies (GWAS) with sparse and incongruent results. We reviewed recent evidence on host genetic susceptibility to TB, highlighting population-specific characteristics, host–pathogen coevolution, and the limitations of conventional GWAS approaches in terms of clinical and genetic heterogeneity. While rare variants with high penetrance, such as TYK2 P1104A, lead to monogenic susceptibility, most heritable risk results from the cumulative effect of numerous common variants. This cumulative effect may be summarized using polygenic risk scores (PRSs). Although their use has been proven for non-communicable diseases, PRSs are not applied to infectious disease susceptibility. To date, no PRS model for susceptibility to tuberculosis has been consistently validated. The development of PRSs for TB susceptibility is limited by phenotypic heterogeneity, population structure, and co-adaptation between host and pathogen. Another major challenge is to take into account the considerable influence of environmental factors. This difficulty in modeling environmental influences probably explains the current lack of a clinically applicable PRS for TB susceptibility. However, taking these caveats into account, polygenic models could improve risk stratification at the individual level compared to single-variant association and allow for earlier targeted treatment and prophylaxis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical and Biological Agency, 119121 Moscow, Russia.
- Department of Biomedicine, Pirogov Medical University, 117997 Moscow, Russia.
- Laboratory of Postgenomic Technologies, Izmerov Research Institute of Occupational Health, 105275 Moscow, Russia.
ORCID-Profile: Mariia A Dashian, German A Shipulin, Andrei A Deviatkin
Zitieren
APA
Dashian, M. A., Shipulin, G. A., & Deviatkin, A. A. (2025). Genetic Susceptibility to Tuberculosis and the Utility of Polygenic Scores in Population Stratification. International Journal of Molecular Sciences, 26(19), 9544. https://doi.org/10.3390/ijms26199544
Vancouver
Dashian MA, Shipulin GA, Deviatkin AA. Genetic Susceptibility to Tuberculosis and the Utility of Polygenic Scores in Population Stratification. International Journal of Molecular Sciences. 2025;26(19):9544. doi:10.3390/ijms26199544
BibTeX
@article{Dashian2025,
author = {Dashian, Mariia A and Shipulin, German A and Deviatkin, Andrei A},
title = {Genetic Susceptibility to Tuberculosis and the Utility of Polygenic Scores in Population Stratification},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {19},
pages = {9544},
doi = {10.3390/ijms26199544}
}
EUVIMED